Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. - Jahan N; Taraba J; Boddicker NJ; Giridhar KV; Leon-Ferre RA; Tevaarwerk AJ; Cathcart-Rake E; O'Sullivan CC; Peethambaram PP; Hobday TJ; Mina LA; Batalini F; et al. (Clinical breast cancer, 2025)